Optical Genome Mapping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Consumables v/s Instruments), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End User (Research and Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Others) By Region, Competition Forecast and Opportunities

  • Industry : Healthcare
  • Pages : 205
  • Published Date : June, 2022
Customization Enquiry

Buy Now

Summary

Report Description

Global optical genome mapping market stood at USD101.11 Million in 2021 and is expected to grow at a CAGR of 19.73% during the forecast period. This can be ascribed to medical advances in finding effective and efficient treatments for various chronic diseases that are constantly evolving. The optical genome mapping method is highly accurate and cost-effective, and these benefits are expected to drive the worldwide optical genome mapping market in the next five years. Furthermore, the market's expansion is being aided by an increase in biotechnology studies and research. In the next five years, one of the primary reasons for the worldwide optical genome mapping market will improve microbiological approaches for new drug discovery and development and treatment procedures. The optical genome mapping is used to map small structural differences in the genomes of bacteria and protists for medication discovery. The global optical genome mapping market is aided by rapidly expanding biotechnology and pharmaceutical breakthroughs for drug manipulation and innovation for various disease treatments.

Sudden Outbreak & Spread of COVID-19 Driving Market Growth

The global coronavirus outbreak wreaked havoc on the supply chain. Lockdowns were imposed to stop the virus from spreading, resulting in local borders, reduced air travel, and a trade prohibition. Furthermore, due to the shutdown of several industries, there were several challenges with the supply of consumables, reagents, and instruments required in optical genome mapping. All of this resulted in a shortage of consumables, reagents, and instruments in some nations and hoarding in countries that manufacture these items. Furthermore, since academic and research institutes were either shut down or concentrated on creating a therapy for new coronavirus, there was an interruption in research and development efforts linked to optical genome mapping. On the other hand, the biotechnology and pharmaceutical industries were equally committed to finding a cure for novel coronavirus.

Increasing Awareness for Prenatal Testing Supporting Market Growth

The need for procedures like optical genome mapping has expanded as the public's understanding of prenatal testing has grown. Optical genome mapping (OGM) is a novel technology that outperforms existing methods by detecting all sorts of structural variants (SVs), including copy number variations (CNVs). Laboratories utilize the method to diagnose hematological malignancies and prenatal and postnatal constitutional genetic disorders. The use of this technology in prenatal testing and the diagnosis of various genetic abnormalities has been demonstrated in studies. This, in turn, is likely to fuel market expansion.

Growing Demand of Personalized Medicine to Support Market Growth

The procedure aids in the treatment of cancer in a far more effective and efficient manner, as previous methods of detection, such as histology, DNA sequencing, karyotyping, fluorescence in situ hybridization, and chromosomal microarray analysis, have difficulty in detecting the exact site of treatment, with the risk of missing the accurate site of action. They have not been able to detect the genetic variation. Optical genetic mapping comes into play by determining the exact position and variance in genetic coding. This also entails less time commitment, which means less time on report generation and patient treatment. The market is being driven by increased demand for personalized pharmaceuticals. Optical genome mapping will play a role in situations where a novel variation develops for which no indication is available.

Inefficiency of Next Generation Sequencing Supporting Market Growth of Optical Genome Mapping Market

The detection of sequence variations is a strength of Next-Generation Sequencing (NGS) technology. They are unable to recognize repeat regions of the genome, which limits their ability to detect all structural variants. In clinical laboratories around the world, a variety of molecular methods are used to discover repeat expansion and contraction problems. Optical genome mapping, on the other hand, can detect repeat regions of the genome as well as all forms of structural variants, giving it an advantage over present sequencing technologies.


Click here to download the sample

Market Segmentation

The global optical genome mapping market is segmented based on product, application, end user. Based on product, the market can be split into consumables and instruments. Based on application, the market can be divided into genome assembly, structural variation detection, microbial strain typing, haplotype phasing, others. Based on end user, the market can be segmented into research & academic institutions, biotechnology & pharmaceutical companies, clinical laboratories, others. Regionally, North America dominated the market in 2021, with United States being the largest market. United States optical genome mapping market stood at USD38.95 million in 2021 on account of widespread use of this technique across academic and research institutions in the country.

Company Profiles

Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, Praxis Genomics LLC, PerkinElmer, Inc., OpGen, Inc., are among the major market players operating in the global optical genome mapping market.

Attribute

Details

Market size value in 2021

USD101.11 Million

Revenue Forecast in 2027

USD288.33 Million

United States Market Size Value in 2021

USD38.95 Million

Growth Rate

19.73%

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Product

·         Application

·         End User

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; France; United Kingdom; Germany; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE;

Key Companies Profiled

Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, Praxis Genomics LLC, PerkinElmer, Inc., OpGen, Inc

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, global optical genome mapping market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Optical Genome Mapping Market, By Product:
    • Consumables
    • Instruments
  • Optical Genome Mapping Market, By Application:
    • Genome Assembly
    • Structural Variation Detection
    • Microbial Strain Typing
    • Haplotype Phasing
    • Others
  • Optical Genome Mapping Market, By End User:
    • Research & Academic Institutions
    • Biotechnology & Pharmaceutical Companies
    • Clinical Laboratories
    • Others
  • Optical Genome Mapping Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • United Kingdom
      • Germany
      • Spain
      • Italy
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Optical Genome Mapping market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Optical Genome Mapping Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Optical Genome Mapping Awareness

5.2.  Brand Awareness

5.3.  Factors Contributing Switch to Optical Genome Mapping

6.    Global Optical Genome Mapping Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Product (Consumables v/s Instruments)

6.2.2.   By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others)

6.2.3.    By End User (Research & Academic Institutions, Biotechnology & Pharmaceutical        Companies, Clinical Laboratories, Others)

6.2.4.    By Region

6.2.5.    By Company (2021)

6.3.  Market Map (By Product, By Application, By End User, By Region)

7.    North America Optical Genome Mapping Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Product

7.2.2.    By Application

7.2.3.    By End User

7.2.4.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Optical Genome Mapping Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Product

7.3.1.2.2.           By Application

7.3.1.2.3.           By End User

7.3.2.    Canada Optical Genome Mapping Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Product

7.3.2.2.2.           By Application

7.3.2.2.3.           By End User

7.3.3.    Mexico Optical Genome Mapping Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Product

7.3.3.2.2.           By Application

7.3.3.2.3.           By End User

8.    Europe Optical Genome Mapping Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Product

8.2.2.    By Application

8.2.3.    By End User

8.2.4.    By Country

8.3.  Europe: Country Analysis

8.3.1.    France Optical Genome Mapping Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Product

8.3.1.2.2.           By Application

8.3.1.2.3.           By End User

8.3.2.    United Kingdom Optical Genome Mapping Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Product

8.3.2.2.2.           By Application

8.3.2.2.3.           By End User

8.3.3.    Germany Optical Genome Mapping Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Product

8.3.3.2.2.           By Application

8.3.3.2.3.           By End User

8.3.4.    Italy Optical Genome Mapping Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Product

8.3.4.2.2.           By Application

8.3.4.2.3.           By End User

8.3.5.    Spain Optical Genome Mapping Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Product

8.3.5.2.2.           By Application

8.3.5.2.3.           By End User

9.    Asia-Pacific Optical Genome Mapping Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Product

9.2.2.    By Application

9.2.3.    By End User

9.2.4.    By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.    China Optical Genome Mapping Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Product

9.3.1.2.2.           By Application

9.3.1.2.3.           By End User

9.3.2.    India Optical Genome Mapping Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Product

9.3.2.2.2.           By Application

9.3.2.2.3.           By End User

9.3.3.    Japan Optical Genome Mapping Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Product

9.3.3.2.2.           By Application

9.3.3.2.3.           By End User

9.3.4.    South Korea Optical Genome Mapping Market Outlook

9.3.4.1.        Market Size & Forecast

9.3.4.1.1.           By Value

9.3.4.2.        Market Share & Forecast

9.3.4.2.1.           By Product

9.3.4.2.2.           By Application

9.3.4.2.3.           By End User

9.3.5.    Australia Optical Genome Mapping Market Outlook

9.3.5.1.        Market Size & Forecast

9.3.5.1.1.           By Value

9.3.5.2.        Market Share & Forecast

9.3.5.2.1.           By Product

9.3.5.2.2.           By Application

9.3.5.2.3.           By End User

10. South America Optical Genome Mapping Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Product

10.2.2. By Application

10.2.3. By End User

10.2.4. By Country

10.3.             South America: Country Analysis

10.3.1. Brazil Optical Genome Mapping Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Product

10.3.1.2.2.         By Application

10.3.1.2.3.         By End User

10.3.2. Argentina Optical Genome Mapping Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Product

10.3.2.2.2.         By Application

10.3.2.2.3.         By End User

10.3.3. Colombia Optical Genome Mapping Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Product

10.3.3.2.2.         By Application

10.3.3.2.3.         By End User

11. Middle East and Africa Optical Genome Mapping Market Outlook

11.1.             Market Size & Forecast        

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Product

11.2.2. By Application

11.2.3. By End User

11.2.4. By Country

11.3.             MEA: Country Analysis

11.3.1. South Africa Optical Genome Mapping Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Product

11.3.1.2.2.         By Application

11.3.1.2.3.         By End User

11.3.2. Saudi Arabia Optical Genome Mapping Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Product

11.3.2.2.2.         By Application

11.3.2.2.3.         By End User

11.3.3. UAE Optical Genome Mapping Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Product

11.3.3.2.2.         By Application

11.3.3.2.3.         By End User

12. Market Dynamics

12.1.             Drivers

12.2.             Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1.             Competition Outlook

14.2.             Company Profiles (SWOT Analysis of Top 5 Players Profiled)

14.2.1. Bionano Genomics, Inc.

14.2.2. Nabsys Inc

14.2.3. Nucleome Informatics Pvt Ltd

14.2.4. France Génomique

14.2.5. Praxis Genomics LLC

14.2.6. PerkinElmer, Inc.

14.2.7. OpGen, Inc.

15. Strategic Recommendations

Figures and Tables

List of Figures:

Figure 1: Global Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 3: Global Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 4: Global Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 5: Global Optical Genome Mapping Market Share, By Region, By Value, 2017-2027F
Figure 6: Global Optical Genome Mapping Market Share, By Company, By Value, 2021
Figure 7: Global Optical Genome Mapping Market Map, By Product, Market Size (USD Million) & Growth Rate (%), 2021
Figure 8: Global Optical Genome Mapping Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Optical Genome Mapping Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Optical Genome Mapping Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: North America Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 12: North America Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 13: North America Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 14: North America Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 15: North America Optical Genome Mapping Market Share, By Country, By Value, 2017-2027F
Figure 16: United States Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 17: Total Human Genome Project Funding By National Institutes for Health in United States (USD Million), 2017-2021 
Figure 18: United States Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 19: United States Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 20: United States Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 21: Canada Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 22: Death Rate for Congenital Malformations, Deformations and Chromosomal Abnormalities in Canada (Per 100, 000 population), 2017-2021
Figure 23: Canada Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 24: Canada Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 25: Canada Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 26: Mexico Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 27: Mexico Research and Development Expenditure As a Percentage of GDP, 2017-2021
Figure 28: Mexico Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 29: Mexico Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 30: Mexico Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 31: Europe Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 32: Europe Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 33: Europe Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 34: Europe Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 35: Europe Optical Genome Mapping Market Share, By Country, By Value, 2017-2027F
Figure 36: France Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 37: Number of Physicians Specializing in Medical Genetics in France in 2020, By Region
Figure 38: France Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 39: France Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 40: France Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 41: United Kingdom Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 42: Number of Companies in the Life Science Industry Sector in the United Kingdom, By Sector, 2020
Figure 43: United Kingdom Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 44: United Kingdom Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 45: United Kingdom Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 46: Germany Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 47: Germany Healthcare Expenditure, By Value (USD Billion), 2017-2020
Figure 48: Germany Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 49: Germany Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 50: Germany Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 51: Italy Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 52: Number of Cystic Fibrosis Patients in Italy, By Age, As of January 2020
Figure 53: Italy Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 54: Italy Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 55: Italy Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 56: Spain Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 57: Number of Individuals Suffering from Alzheimer’s Disease in Spain, 2020, 2025, 2030, 2035, 2040
Figure 58: Spain Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 59: Spain Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 60: Spain Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 61: Asia-Pacific Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 62: Asia-Pacific Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 63: Asia-Pacific Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 64: Asia-Pacific Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 65: Asia-Pacific Optical Genome Mapping Market Share, By Country, By Value, 2017-2027F
Figure 66: China Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 67: Internal Research & Development Spending in China, (USD Billion), 2017-2021
Figure 68: China Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 69: China Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 70: China Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 71: India Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 72: Number of Hospitals in India, As of April 2020
Figure 73: India Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 74: India Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 75: India Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 76: Japan Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 77: Percentage of People Aged 65 years and older among Total Population in Japan, 2017-2021
Figure 78: Japan Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 79: Japan Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 80: Japan Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 81: South Korea Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 82: South Korea National Health Expenditure as a Percent of GDP, 2017-2020
Figure 83: South Korea Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 84: South Korea Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 85: South Korea Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 86: Australia Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 87: Most Prevalent Chronic Conditions Experienced in Australia, 2020-2021
Figure 88: Australia Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 89: Australia Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 90: Australia Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 91: South America Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 92: South America Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 93: South America Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 94: South America Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 95: South America Optical Genome Mapping Market Share, By Country, By Value, 2017-2027F
Figure 96: Brazil Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 97: Total Medical Genetics Workforce in Brazil, 2020
Figure 98: Brazil Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 99: Brazil Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 100: Brazil Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 101: Argentina Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 102: Hospital Infrastructure in Argentina (In Thousands), By Type, 2022
Figure 103: Argentina Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 104: Argentina Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 105: Argentina Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 106: Colombia Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 107: Colombia Total Healthcare Expenditure (USD Billion), 2017-2021
Figure 108: Colombia Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 109: Colombia Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 110: Colombia Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 111: Middle East & Africa Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 112: Middle East & Africa Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 113: Middle East & Africa Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 114: Middle East & Africa Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 115: Middle East & Africa Optical Genome Mapping Market Share, By Country, By Value, 2017-2027F
Figure 116: South Africa Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 117: Total Population of South Africa, 2017-2021 (in 1,000s)
Figure 118: South Africa Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 119: South Africa Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 120: South Africa Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 121: Saudi Arabia Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 122: Saudi Arabia Geriatric Population (Aged 65 & Above) As a Percent of Total Population, 2016-2020
Figure 123: Saudi Arabia Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 124: Saudi Arabia Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 125: Saudi Arabia Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F
Figure 126: UAE Optical Genome Mapping Market Size, By Value (USD Million), 2017-2027F
Figure 127: UAE Outpatient Healthcare Expenditure (USD Billion), 2017-2021
Figure 128: UAE Optical Genome Mapping Market Share, By Product, By Value, 2017-2027F
Figure 129: UAE Optical Genome Mapping Market Share, By Application, By Value, 2017-2027F
Figure 130: UAE Optical Genome Mapping Market Share, By End User, By Value, 2017-2027F

List of Tables:

Table 1: Global Cancer Statistics, 2020
Table 2: Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020
Table 3: North America Cancer Statistics, 2020
Table 4: Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020
Table 7: Asia-Pacific Cancer Statistics, 2020
Table 8: Total Number of New Cancer Cases and Deaths Reported in Asia-Pacific, By Type, 2020
Table 9: South America Cancer Statistics, 2020
Table 10: Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020
Table 11: Middle East & Africa Cancer Statistics, 2020
Table 12: Total Number of New Cancer Cases and Deaths Reported in Middle East, By Type, 2020

Frequently asked questions

down-arrow

Global optical genome mapping market is projected to grow at a CAGR of 19.73% and reach USD288.33 million by 2027 on account of the growing prevalence of different genetic disorders and chronic diseases such as cancer.

down-arrow

Asia Pacific optical genome mapping market is expected to register the highest growth of 21.22% during the forecast period. This can be attributed to the extensive research & development activities, ongoing clinical trials, increasing investments, and expansion of companies in the region.

down-arrow

Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, among others are some of the leading players operating in the global optical genome mapping market.

down-arrow

Some factors impeding the growth of the global optical genome mapping market include lack of awareness and adoption of technique, lack of skilled professionals to use the instruments, consumables, and experiment.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Optical Genome Mapping Market To Register CAGR of 19.73% until 2027

Jun, 2022

Increasing medical progress in the search for effective and efficient therapies for a variety of chronic conditions is driving the growth in global optical genome mapping market in the forecast perio

Why Choose Us